Mirum Pharmaceuticals, Inc. (MIRM)
66.44
-1.46
(-2.15%)
USD |
NASDAQ |
Dec 09, 11:50
Mirum Pharmaceuticals EPS Diluted (Quarterly): 0.051 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arcutis Biotherapeutics, Inc. | 0.0558 |
| Insmed, Inc. | -1.747 |
| CorMedix, Inc. | 1.259 |
| ADMA Biologics, Inc. | 0.1489 |
| Stoke Therapeutics, Inc. | -0.6543 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 2.905M |
| Revenue (Quarterly) | 133.01M |
| Total Expenses (Quarterly) | 130.10M |
| Enterprise Value | 3.433B |
| Gross Profit Margin (Quarterly) | 80.75% |
| Profit Margin (Quarterly) | 2.18% |
| Earnings Yield | -1.30% |
| Normalized Earnings Yield | -1.297 |